http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2007148081-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-0005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J71-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J53-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J53-00 |
| filingDate | 2006-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2009-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2007148081-A |
| titleOfInvention | COMPOUNDS USED FOR TREATMENT OF NEURODEGENERATIVE DISORDERS |
| abstract | 1. The compound of formula I:! ! or its pharmaceutically acceptable salt, where:! each of rings A, B, C, D, and E independently represents a saturated, partially unsaturated, or aromatic ring; ! G represents S, CH2, NR or O; ! each R1 and R2 independently represents a halogen, R, OR, a suitably protected hydroxyl group, SR, a suitably protected thiol group, N (R) 2 or a suitably protected amino group, or R1 and R2 together form a 3-7 membered saturated, partially unsaturated or aryl ring containing 0-2 heteroatoms independently selected from the group: nitrogen, oxygen, sulfur; ! each R independently represents hydrogen, a possibly substituted C1-6 aliphatic group, or a possibly substituted 3-8 membered saturated, partially unsaturated or aryl ring containing 0-4 heteroatoms independently selected from the group: nitrogen, oxygen and sulfur, where: ! two Rs at one nitrogen atom, possibly together with the specified nitrogen atom, form a 3-8-membered saturated, partially unsaturated or aryl ring containing 1-4 heteroatoms independently selected from the group: nitrogen, oxygen and sulfur; ! n takes the value 0-2; ! each R3, R4, R7 and R8 is independently selected from the group: halogen, R, OR, appropriately substituted hydroxyl group, SR, appropriately substituted thiol group, SO2R, OSO2R, N (R) 2, appropriately protected amino group, NR (CO) R, NR (CO) (CO) R, NR (CO) N (R) 2, NR (CO) OR, (CO) OR, O (CO) R, (CO) N (R) 2, or O (CO) N (R) 2; ! m takes the value 0-2; ! R5 is TC (R ') 3, TC (R') 2C (R ') 3, R, OR, a suitably protected hydroxyl group, SR, a suitably protected thiol group, SO2R, OSO2R, N (R) 2, respectively |
| priorityDate | 2005-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.